The following statement is not true about the use of clonidine in the treatment of hypeension ?
**Question:** The following statement is not true about the use of clonidine in the treatment of hypertension?
A. Clonidine reduces blood pressure by blocking alpha-1 receptors
B. Clonidine increases heart rate
C. Clonidine has a shorter duration of action than other antihypertensive medications
D. Clonidine is contraindicated in patients with renal impairment
**Correct Answer:** C. Clonidine has a shorter duration of action than other antihypertensive medications
**Core Concept:**
Clonidine is a centrally-acting alpha-2 agonist with potent antihypertensive properties. It works by stimulating alpha-2 receptors, which leads to vasodilation, reduced cardiac output, and decreased renin release. This results in a decrease in blood pressure and heart rate.
**Why the Correct Answer is Right:**
Clonidine has a longer duration of action compared to other antihypertensive medications like beta-blockers or calcium channel blockers. Its longer duration allows for once-daily dosing and ensures consistent blood pressure control throughout the day.
**Why Each Wrong Option is Incorrect:**
A. Clonidine reduces blood pressure by blocking alpha-1 receptors: This is incorrect because clonidine, as a selective alpha-2 agonist, actually reduces blood pressure by stimulating alpha-2 receptors.
B. Clonidine increases heart rate: This is incorrect as clonidine leads to a decrease in heart rate due to its effect on cardiac sympathetic input.
C. Clonidine has a shorter duration of action than other antihypertensive medications: As mentioned earlier, clonidine has a longer duration of action compared to other medications like beta-blockers or calcium channel blockers. This is why clonidine is typically administered once daily, ensuring consistent blood pressure control throughout the day.
D. Clonidine is contraindicated in patients with renal impairment: Although clonidine is not recommended for patients with severe renal impairment due to the potential for accumulation and toxicity, it is generally safe for patients with mild to moderate renal impairment.
**Clinical Pearls:**
1. Clonidine is a valuable option for the treatment of hypertension, especially in patients with renal impairment or those who cannot tolerate other antihypertensive medications due to potential side effects or contraindications.
2. In clinical practice, it is essential to monitor patients on clonidine therapy closely for potential side effects like sedation, dry mouth, dizziness, and hypotension.